|1.||Chalmers, John: 18 articles (01/2015 - 05/2003)|
|2.||Woodward, Mark: 13 articles (01/2015 - 05/2003)|
|3.||MacMahon, Stephen: 9 articles (01/2015 - 05/2003)|
|4.||Patel, Anushka: 8 articles (10/2014 - 01/2007)|
|5.||Peters, Ruth: 8 articles (03/2013 - 01/2006)|
|6.||Poulter, Neil: 6 articles (01/2015 - 05/2009)|
|7.||Safar, Michel E: 6 articles (01/2015 - 08/2002)|
|8.||Arima, Hisatomi: 6 articles (10/2014 - 06/2006)|
|9.||Neal, Bruce: 6 articles (10/2014 - 05/2003)|
|10.||Beckett, Nigel: 6 articles (03/2013 - 01/2006)|
|1.||Hypertension (High Blood Pressure)
03/01/2003 - "This study will complete the knowledge of the efficacy of indapamide SR in hypertension and target organ damage and will provide valuable information on the management of type 2 diabetic hypertensives with microalbuminuria."
01/01/1994 - "These results confirm the clinical efficacy of indapamide and its beneficial effects on quality of life in patients with mild and moderate hypertension when administered in monotherapy."
09/01/1984 - "Thus, indapamide appears to offer a suitable alternative to more established drugs as a 'first-line' treatment in patients with mild to moderate hypertension. "
09/28/2001 - "Indapamide is an oral diuretic antihypertensive drug effective for patients with mild or moderate essential hypertension. "
03/01/1983 - "Indapamide: clinical pharmacology, therapeutic efficacy in hypertension, and adverse effects."
06/01/2013 - "It is mainly the combination of an ACE inhibitor + indapamide that seems to be modern and promising, and it is, on the basis of large clinical trials, recommended also for diabetics (ADVANCE) or for secondary prevention following a cerebrovascular accident (PROGRESS) or for the elderly (HYVET). "
09/01/1995 - "The findings of this trial indicate that in patients with a history of stroke or TIA, blood pressure reduction of 5/2 mmHg with 2.5 mg indapamide reduced the first incidence of fatal and nonfatal stroke by 29%, with three-year absolute benefit of 29 events per 1000 participants."
11/01/2009 - "In conclusion, BP lowering by indapamide treatment reduced the recurrence of stroke and the incidence of cardiovascular events in Chinese patients with cerebrovascular disease. "
11/01/2009 - "In total, 143 patients on indapamide and 219 patients on placebo had recurrent strokes (hazard ratio for indapamide, 0.69; 95% confidence interval (CI): 0.54-0.89; P<0.001). "
07/01/2007 - "Indapamide is efficacious in prevention of further stroke, reduces effectively the blood pressure and the left ventricular mass index. "
|3.||Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
05/01/2004 - "Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide."
10/01/2000 - "Effects of indapamide in rats with pressure overload left ventricular hypertrophy."
01/01/1993 - "Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study."
12/01/1990 - "The effects of a diuretic, indapamide, on the regression of left ventricular hypertrophy were studied in a group of 9 patients with mild hypertension treated in an open therapeutic trial over a 12 month period. "
07/01/2012 - "Indapamide has protecting effects in a variety of conditions associated with high cardiovascular risk, such as diabetes, left ventricular hypertrophy, nephropathy and stroke. "
01/01/1993 - "Morphometric analysis of myocyte cross-sectional areas evidenced that indapamide was the most effective in preventing myocyte hypertrophy (-33%, p < or = 0.0001). "
02/01/2001 - "Significant hypertrophy regression with indapamide sustained release 1.5 mg."
08/01/2009 - "It is concluded that the complex protective effects of the combined indapamide plus captopril treatment on hypertension may be exerted via its effects on blood pressure, hypertrophy and vasorelaxation."
08/01/1999 - "In experimental models of hypertension, perindopril/indapamide restored endothelial function, improved microvascular density, reduced left ventricular and aortic hypertrophy, and reversed renal end-organ damage. "
01/01/2011 - "The aim of this study was to analyze the effect of indapamide and its combination with ACE inhibitor (captopril) and antioxidant (Provinols™) on both myocardial hypertrophy and fibrosis. "
01/01/1984 - "Indapamide, a new antihypertensive/diuretic agent, in the treatment of patients with edema."
07/01/1983 - "Clinical efficacy and safety of indapamide in the treatment of edema."
01/01/2013 - "Authors aimed to present a rare case of indapamide-induced transient myopia with ciliary body edema and supraciliary effusion. "
07/01/1983 - "Indapamide is a new antihypertensive diuretic agent indicated for the treatment of hypertension and edema. "
07/01/1983 - "This study concluded that indapamide in once-daily oral doses of 2.5, 5.0, or 10.0 mg was as safe and effective as a once-daily 100 mg dose of hydrochlorothiazide for the treatment of 219 patients with edema from various causes."
|4.||Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
|5.||Antihypertensive Agents (Antihypertensives)
|1.||Drug Therapy (Chemotherapy)
|3.||Renal Dialysis (Hemodialysis)
|5.||Protein-Restricted Diet (Diet, Protein Restricted)